Antiretroviral drug levels and interactions affect lipid, lipoprotein, and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic- pharmacodynamic analysis

Authors

Susan Rosenkranz, Harvard University
Kevin E. Yarasheski, Washington University School of Medicine in St. Louis
Michael F. Para, Ohio State University - Main Campus
Richard C. Reichman, University of Rochester
Gene D. Morse, State University of New York

Journal

Metaboloic Syndrome and Related Disorders

Publication Date

2007

Volume

5

Issue

2

Inclusive Pages

163-173

Document Type

Open Access Publication

DOI

10.1089/met.2006.0034

Rights and Permissions

Rosenkranz, S. L., Yarasheski, K. E., Para, M. F., Reichman, R. C., & Morse, G. D. (2007). Antiretroviral drug levels and interactions affect lipid, lipoprotein, and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic- pharmacodynamic analysis. Metabolic Syndrome and Related Disorders, 5(2), 163-173. DOI: 10.1089/met.2006.0034. This is a copy of an article published in Metaboloic syndrome and related disorders ©2007 [copyright Mary Ann Liebert, Inc.]; Metaboloic syndrome and related disorders is available online at: http://online.liebertpub.com.

Recommended Citation

Rosenkranz, Susan; Yarasheski, Kevin E.; Para, Michael F.; Reichman, Richard C.; and Morse, Gene D., "Antiretroviral drug levels and interactions affect lipid, lipoprotein, and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic- pharmacodynamic analysis." Metaboloic Syndrome and Related Disorders. 5, 2. 163-173. (2007).
https://digitalcommons.wustl.edu/open_access_pubs/3093